Abstract:In cells of the myeloid lineage, NLRP3 stimulation leads to disassembly of the trans‐Golgi network (TGN). The resulting dispersed TGN serves as a scaffold for NLRP3 aggregation, leading to cytokine production and pyroptosis. In contrast, it is proposed that the magnitude of interactions between the polybasic motif of NLRP3 and the TGN in adaptive immunity is low, which triggers cytokine production, but does not result in pyroptotic cell death. Eukaryotic cells are equipped with cytoplasmic sensors that recognize diverse pathogen‐ or danger‐associated molecular patterns. In cells of the myeloid lineage, activation of these sensors leads to the assembly of a multimeric protein complex, called the inflammasome, that culminates in the production of inflammatory cytokines and pyroptosis. Recently, investigation of the inflammasomes in lymphocytes led to the discovery of functional pathways that were initially believed to be confined to the innate arm of the immune system. Thus, the adapter protein apoptosis‐associated speck‐like protein containing a CARD (ASC) was documented to play a critical role in antigen uptake by dendritic cells, and regulation of T‐ and B‐cell motility at several stages, and absent in melanoma 2 (AIM2) was found to act as a modulator of regulatory T‐cell differentiation. Remarkably, NLRP3 was demonstrated to act as a transcription factor that controls Th2 cell polarization, and as a negative regulator of regulatory T‐cell differentiation by limiting Foxp3 expression. In B lymphocytes, NLRP3 plays a role in the transcriptional network that regulates B‐cell development and homing, and its activation is essential for germinal center formation and maturation of high‐affinity antibody responses. Such recently discovered inflammasome‐mediated functions in T and B lymphocytes offer multiple cross‐talk opportunities for the innate and adaptive arms of the immune system. A better understanding of the dialog between inflammasomes and intracellular components could be beneficial for therapeutic purposes in restoring immune homeostasis and mitigating inflammation in a wide range of disorders.

How Inflammasomes Inform Adaptive Immunity

Activation and Pharmacological Regulation of Inflammasomes

The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

Swaying the advantage: multifaceted functions of inflammasomes in adaptive immunity

Inflammasome activation: from molecular mechanisms to autoinflammation

Inflammasome Contribution to the Activation of Th1, Th2, and Th17 Immune Responses

Inflammasome activation and Th17 responses.

Inflammasomes: Key Mediators of Lung Immunity

Regulation of adaptive immunity by the NLRP3 inflammasome.

Function of Inflammasomes in Anti-microbial Infections

Inflammasomes: mechanism of action, role in disease, and therapeutics

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

Inflammasome in Dendritic Cells Immunobiology: Implications to Diseases and Therapeutic Strategies

Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis

Inflammasomes and their roles in health and disease

Enigmatic inflammasomes

Inflammasome functional activities in B lymphocytes

Research Progress of NLRP3 Inflammasome and Adaptive Immunity

Initiation and perpetuation of NLRP3 inflammasome activation and assembly

[Inflammasome and interleukin 1]

NLRP Inflammasomes in Health and Disease.